Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Microneedle Patch for Low-Cost, Intradermal IPV Vaccination

Mark Prausnitz of Georgia Institute of Technology and Steve Oberste of the Centers for Disease Control and Prevention in the U.S. will test the feasibility of using microneedle patches to deliver the inactivated polio vaccine (IPV) instead of using intramuscular vaccine shots. This new method is designed to lower the required dose, simplify vaccination procedures, and eliminate dangers associated with hypodermic needles.

More information about The Poliovirus Endgame: Create Innovative Ways to Accelerate, Sustain, and Monitor Eradication (Round 7)